Multiple Myeloma Hub cover image

What are the pros and cons of bispecific antibodies for multiple myeloma?

Multiple Myeloma Hub

CHAPTER

Exploring the Use of Bispecific Antibodies in Multiple Myeloma Treatment

Exploring the potential benefits and considerations of using bispecific antibodies as a fixed duration therapy for multiple myeloma, enhancing efficacy while minimizing infection risks and allowing immune system recovery.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner